United States Pharmaceuticals

Greenwich Lifesciences Inc (GLSI)

Track

Track

Greenwich Lifesciences Inc. witnessed significant insider trading activity recently, with CEO and CFO Snehal Patel executing five consecutive buy transactions totaling $97,003. These acquisitions occurred despite a 37.5% decline in stock price over the last quarter. The company's latest results financiers showed an 18.18% earnings beat, reflecting ongoing operational developments.
Ticker: GLSI Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Greenwich Lifesciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
27.66
Quantity 50,376 +6.1%
Value US$1,147,168
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
335.26
Quantity 57,915 -48.0%
Value US$2,354,612
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
183.16
Quantity 10,182 -37.9%
Value US$4,591,592
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
12.88
Quantity 1,100 +0.0%
Value US$14,168
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
13.14
Quantity 2,500 +0.0%
Value US$32,850
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
29.83
Quantity 1,800 +0.0%
Value US$53,694
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
27.54
Quantity 2,900 +0.1%
Value US$79,866
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
21.36
Quantity 4,300 +0.1%
Value US$91,848
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
21.73
Quantity 2,900 +0.1%
Value US$63,017
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
12.62
Quantity 4,100 +0.1%
Value US$51,742
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
8.37
Quantity 4,600 +0.1%
Value US$38,502
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
8.43
Quantity 10,600 +0.2%
Value US$89,358
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
9.26
Quantity 2,300 +0.0%
Value US$21,298
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
9.88
Quantity 3,600 +0.1%
Value US$35,568
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
8.98
Quantity 5,400 +0.1%
Value US$48,492
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
9.10
Quantity 3,600 +0.1%
Value US$32,760
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
8.73
Quantity 5,500 +0.1%
Value US$48,015
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
12.51
Quantity 2,500 +0.0%
Value US$31,275
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
13.75
Quantity 1,800 +0.0%
Value US$24,750
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
13.31
Quantity 1,100 +0.0%
Value US$14,641
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
12.95
Quantity 3,400 +0.1%
Value US$44,030
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
11.97
Quantity 2,000 +0.0%
Value US$23,940
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
11.36
Quantity 2,400 +0.0%
Value US$27,264
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
11.12
Quantity 3,200 +0.1%
Value US$35,584
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
12.91
Quantity 1,000 +0.4%
Value US$12,910
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
14.63
Quantity 1,500 +0.0%
Value US$21,945
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
13.85
Quantity 800 +0.3%
Value US$11,080
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
13.81
Quantity 2,000 +0.0%
Value US$27,620
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
13.18
Quantity 5,500 +0.1%
Value US$72,490
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
15.15
Quantity 1,000 +0.4%
Value US$15,150
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
15.89
Quantity 1,500 +0.0%
Value US$23,835
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
16.00
Quantity 1,000 +0.4%
Value US$16,000
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
14.30
Quantity 174,825 +3.3%
Value US$2,499,998
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
19.08
Quantity 3,000 +0.1%
Value US$57,240
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
19.98
Quantity 2,500 +0.0%
Value US$49,950
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
17.68
Quantity 1,500 +0.0%
Value US$26,520
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
12.49
Quantity 30,500 +0.6%
Value US$380,945
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
13.03
Quantity 4,100 +0.1%
Value US$53,423
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
11.16
Quantity 10,800 +0.2%
Value US$120,528
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
11.07
Quantity 12,700 +0.2%
Value US$140,589
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
10.17
Quantity 5,000 +0.1%
Value US$50,838
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
9.11
Quantity 3,500 +0.1%
Value US$31,885
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
8.57
Quantity 500 +0.2%
Value US$4,285
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
7.97
Quantity 2,500 +0.0%
Value US$19,925
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
7.91
Quantity 2,500 +0.0%
Value US$19,775
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
9.07
Quantity 1,000 +0.0%
Value US$9,070
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
8.63
Quantity 2,000 +0.0%
Value US$17,260
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
8.71
Quantity 600 +0.2%
Value US$5,226
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
8.95
Quantity 4,000 +0.1%
Value US$35,800
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
9.48
Quantity 1,000 +0.0%
Value US$9,480
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
9.97
Quantity 1,000 +0.0%
Value US$9,970
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
10.55
Quantity 2,000 +0.0%
Value US$21,100
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
9.20
Quantity 1,000 +0.0%
Value US$9,200
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
9.49
Quantity 250 +0.1%
Value US$2,372
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
11.69
Quantity 1,000 +0.0%
Value US$11,690
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
11.22
Quantity 250 +0.1%
Value US$2,805
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
11.10
Quantity 7,000 +0.1%
Value US$77,700
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
11.12
Quantity 2,000 +0.0%
Value US$22,240
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
12.42
Quantity 5,000 +0.1%
Value US$62,100
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
11.87
Quantity 1,000 +0.4%
Value US$11,870
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
12.71
Quantity 250 +0.1%
Value US$3,178
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
12.12
Quantity 1,000 +0.0%
Value US$12,120
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
15.40
Quantity 250 +0.1%
Value US$3,849
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
16.53
Quantity 600 +0.0%
Value US$9,918
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
18.68
Quantity 1,000 +0.0%
Value US$18,680
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
20.84
Quantity 250 +0.1%
Value US$5,210
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
19.35
Quantity 2,000 +0.1%
Value US$38,700
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
19.20
Quantity 250 +0.1%
Value US$4,800
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
17.37
Quantity 1,500 +0.1%
Value US$26,055
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
16.50
Quantity 250 +0.1%
Value US$4,125
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
15.18
Quantity 1,500 +0.1%
Value US$22,770
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
15.19
Quantity 4,000 +0.1%
Value US$60,760
2.4
Thompson Jaye VP Clinical Reg Affairs Officer
Transaction date
Purchase
Price
12.94
Quantity 250 +0.1%
Value US$3,235
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
13.01
Quantity 1,000 +0.0%
Value US$13,010
3.8
Patel Snehal CEO and CFO Executive Director Large shareholder
Transaction date
Purchase
Price
13.11
Quantity 2,000 +0.1%
Value US$26,220
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-30 2026-07-29 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
50,376 +6.1%
27.66
US$1,147,168 		50,376 +6.1% 27.66 US$1,147,168
2026-07-30 2026-07-28 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
57,915 -48.0%
335.26
US$2,354,612 		57,915 -48.0% 335.26 US$2,354,612
2026-07-29 2026-07-27 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
10,182 -37.9%
183.16
US$4,591,592 		10,182 -37.9% 183.16 US$4,591,592
2026-07-27 2026-07-24 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,100 +0.0%
12.88
US$14,168 		1,100 +0.0% 12.88 US$14,168
2026-07-27 2026-07-23 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,500 +0.0%
13.14
US$32,850 		2,500 +0.0% 13.14 US$32,850
2026-01-15 2026-01-13 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,800 +0.0%
29.83
US$53,694 		1,800 +0.0% 29.83 US$53,694
2026-01-14 2026-01-12 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,900 +0.1%
27.54
US$79,866 		2,900 +0.1% 27.54 US$79,866
2026-01-05 2025-12-31 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
4,300 +0.1%
21.36
US$91,848 		4,300 +0.1% 21.36 US$91,848
2026-01-02 2025-12-30 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,900 +0.1%
21.73
US$63,017 		2,900 +0.1% 21.73 US$63,017
2025-12-19 2025-12-18 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
4,100 +0.1%
12.62
US$51,742 		4,100 +0.1% 12.62 US$51,742
2025-11-28 2025-11-25 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
4,600 +0.1%
8.37
US$38,502 		4,600 +0.1% 8.37 US$38,502
2025-11-12 2025-11-07 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
10,600 +0.2%
8.43
US$89,358 		10,600 +0.2% 8.43 US$89,358
2025-11-04 2025-10-31 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,300 +0.0%
9.26
US$21,298 		2,300 +0.0% 9.26 US$21,298
2025-04-29 2025-04-25 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
3,600 +0.1%
9.88
US$35,568 		3,600 +0.1% 9.88 US$35,568
2025-04-22 2025-04-17 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
5,400 +0.1%
8.98
US$48,492 		5,400 +0.1% 8.98 US$48,492
2025-04-08 2025-04-07 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
3,600 +0.1%
9.10
US$32,760 		3,600 +0.1% 9.10 US$32,760
2025-04-07 2025-04-04 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
5,500 +0.1%
8.73
US$48,015 		5,500 +0.1% 8.73 US$48,015
2025-01-13 2025-01-10 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,500 +0.0%
12.51
US$31,275 		2,500 +0.0% 12.51 US$31,275
2025-01-08 2025-01-07 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,800 +0.0%
13.75
US$24,750 		1,800 +0.0% 13.75 US$24,750
2025-01-08 2025-01-06 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,100 +0.0%
13.31
US$14,641 		1,100 +0.0% 13.31 US$14,641
2025-01-07 2025-01-03 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
3,400 +0.1%
12.95
US$44,030 		3,400 +0.1% 12.95 US$44,030
2025-01-06 2025-01-02 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.0%
11.97
US$23,940 		2,000 +0.0% 11.97 US$23,940
2025-01-03 2024-12-31 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,400 +0.0%
11.36
US$27,264 		2,400 +0.0% 11.36 US$27,264
2025-01-02 2024-12-30 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
3,200 +0.1%
11.12
US$35,584 		3,200 +0.1% 11.12 US$35,584
2024-11-25 2024-11-21 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
1,000 +0.4%
12.91
US$12,910 		1,000 +0.4% 12.91 US$12,910
2024-09-30 2024-09-26 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,500 +0.0%
14.63
US$21,945 		1,500 +0.0% 14.63 US$21,945
2024-09-16 2024-08-12 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
800 +0.3%
13.85
US$11,080 		800 +0.3% 13.85 US$11,080
2024-08-08 2024-08-06 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.0%
13.81
US$27,620 		2,000 +0.0% 13.81 US$27,620
2024-08-07 2024-08-05 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
5,500 +0.1%
13.18
US$72,490 		5,500 +0.1% 13.18 US$72,490
2024-08-05 2024-08-02 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
1,000 +0.4%
15.15
US$15,150 		1,000 +0.4% 15.15 US$15,150
2024-07-24 2024-07-23 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,500 +0.0%
15.89
US$23,835 		1,500 +0.0% 15.89 US$23,835
2024-07-22 2024-07-18 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
1,000 +0.4%
16.00
US$16,000 		1,000 +0.4% 16.00 US$16,000
2024-06-17 2024-06-13 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
174,825 +3.3%
14.30
US$2,499,998 		174,825 +3.3% 14.30 US$2,499,998
2024-04-03 2024-04-01 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
3,000 +0.1%
19.08
US$57,240 		3,000 +0.1% 19.08 US$57,240
2024-03-26 2024-03-22 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,500 +0.0%
19.98
US$49,950 		2,500 +0.0% 19.98 US$49,950
2024-03-22 2024-03-20 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,500 +0.0%
17.68
US$26,520 		1,500 +0.0% 17.68 US$26,520
2024-03-07 2024-03-05 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
30,500 +0.6%
12.49
US$380,945 		30,500 +0.6% 12.49 US$380,945
2024-03-06 2024-03-04 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
4,100 +0.1%
13.03
US$53,423 		4,100 +0.1% 13.03 US$53,423
2024-02-21 2024-02-16 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
10,800 +0.2%
11.16
US$120,528 		10,800 +0.2% 11.16 US$120,528
2024-02-20 2024-02-15 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
12,700 +0.2%
11.07
US$140,589 		12,700 +0.2% 11.07 US$140,589
2023-11-14 2023-11-10 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
5,000 +0.1%
10.17
US$50,838 		5,000 +0.1% 10.17 US$50,838
2023-11-07 2023-11-03 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
3,500 +0.1%
9.11
US$31,885 		3,500 +0.1% 9.11 US$31,885
2023-10-31 2023-10-27 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
500 +0.2%
8.57
US$4,285 		500 +0.2% 8.57 US$4,285
2023-10-30 2023-10-26 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,500 +0.0%
7.97
US$19,925 		2,500 +0.0% 7.97 US$19,925
2023-10-27 2023-10-25 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,500 +0.0%
7.91
US$19,775 		2,500 +0.0% 7.91 US$19,775
2023-10-12 2023-10-10 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
9.07
US$9,070 		1,000 +0.0% 9.07 US$9,070
2023-10-05 2023-10-04 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.0%
8.63
US$17,260 		2,000 +0.0% 8.63 US$17,260
2023-09-28 2023-09-26 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
600 +0.2%
8.71
US$5,226 		600 +0.2% 8.71 US$5,226
2023-09-21 2023-09-19 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
4,000 +0.1%
8.95
US$35,800 		4,000 +0.1% 8.95 US$35,800
2023-09-13 2023-09-11 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
9.48
US$9,480 		1,000 +0.0% 9.48 US$9,480
2023-08-24 2023-08-22 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
9.97
US$9,970 		1,000 +0.0% 9.97 US$9,970
2023-08-08 2023-08-04 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.0%
10.55
US$21,100 		2,000 +0.0% 10.55 US$21,100
2023-07-25 2023-07-21 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
9.20
US$9,200 		1,000 +0.0% 9.20 US$9,200
2023-07-17 2023-07-13 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
9.49
US$2,372 		250 +0.1% 9.49 US$2,372
2023-05-18 2023-05-17 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
11.69
US$11,690 		1,000 +0.0% 11.69 US$11,690
2023-05-02 2023-04-28 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
11.22
US$2,805 		250 +0.1% 11.22 US$2,805
2023-04-21 2023-04-19 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
7,000 +0.1%
11.10
US$77,700 		7,000 +0.1% 11.10 US$77,700
2023-04-20 2023-04-18 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.0%
11.12
US$22,240 		2,000 +0.0% 11.12 US$22,240
2023-04-12 2023-04-11 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
5,000 +0.1%
12.42
US$62,100 		5,000 +0.1% 12.42 US$62,100
2023-04-12 2023-04-11 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
1,000 +0.4%
11.87
US$11,870 		1,000 +0.4% 11.87 US$11,870
2023-03-16 2023-03-15 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
12.71
US$3,178 		250 +0.1% 12.71 US$3,178
2023-03-13 2023-03-10 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
12.12
US$12,120 		1,000 +0.0% 12.12 US$12,120
2023-02-28 2023-02-24 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
15.40
US$3,849 		250 +0.1% 15.40 US$3,849
2023-02-22 2023-02-17 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
600 +0.0%
16.53
US$9,918 		600 +0.0% 16.53 US$9,918
2023-02-14 2023-02-10 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
18.68
US$18,680 		1,000 +0.0% 18.68 US$18,680
2023-02-07 2023-02-03 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
20.84
US$5,210 		250 +0.1% 20.84 US$5,210
2023-01-31 2023-01-27 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.1%
19.35
US$38,700 		2,000 +0.1% 19.35 US$38,700
2023-01-30 2023-01-27 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
19.20
US$4,800 		250 +0.1% 19.20 US$4,800
2023-01-24 2023-01-20 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,500 +0.1%
17.37
US$26,055 		1,500 +0.1% 17.37 US$26,055
2023-01-17 2023-01-13 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
16.50
US$4,125 		250 +0.1% 16.50 US$4,125
2023-01-10 2023-01-06 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,500 +0.1%
15.18
US$22,770 		1,500 +0.1% 15.18 US$22,770
2023-01-03 2022-12-29 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
4,000 +0.1%
15.19
US$60,760 		4,000 +0.1% 15.19 US$60,760
2022-12-20 2022-12-16 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
12.94
US$3,235 		250 +0.1% 12.94 US$3,235
2022-12-20 2022-12-16 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
13.01
US$13,010 		1,000 +0.0% 13.01 US$13,010
2022-12-13 2022-12-09 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.1%
13.11
US$26,220 		2,000 +0.1% 13.11 US$26,220
Explore more

More insider trading research around Greenwich Lifesciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America